For: | Dvorak K, Dvorak B. Role of interleukin-6 in Barrett’s esophagus pathogenesis. World J Gastroenterol 2013; 19(15): 2307-2312 [PMID: 23613623 DOI: 10.3748/wjg.v19.i15.2307] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i15/2307.htm |
Number | Citing Articles |
1 |
Toru Narusaka, Toshiaki Ohara, Kazuhiro Noma, Noriyuki Nishiwaki, Yuki Katsura, Takuya Kato, Hiroaki Sato, Yasuko Tomono, Satoru Kikuchi, Hiroshi Tazawa, Yasuhiro Shirakawa, Akihiro Matsukawa, Toshiyoshi Fujiwara. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer. International Journal of Cancer 2021; 149(2): 347 doi: 10.1002/ijc.33544
|
2 |
Christos Triantos, Nikolaos Koukias, Georgios Karamanolis, Konstantinos Thomopoulos. Changes in the esophageal mucosa of patients with non erosive reflux disease: How far have we gone?. World Journal of Gastroenterology 2015; 21(19): 5762-5767 doi: 10.3748/wjg.v21.i19.5762
|
3 |
Paula Roberta Aguiar Pastrez, Ana Margarida Barbosa, Vânia Sammartino Mariano, Rhafaela Lima Causin, Antonio Gil Castro, Egídio Torrado, Adhemar Longatto-Filho. Interleukin-8 and Interleukin-6 Are Biomarkers of Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cancers 2023; 15(7): 1997 doi: 10.3390/cancers15071997
|
4 |
Yan Wang, Xiaoyu Yu, Hongtao Song, Di Feng, Yang Jiang, Shuang Wu, Jingshu Geng. The STAT-ROS cycle extends IFN‑induced cancer cell apoptosis. International Journal of Oncology 2017; doi: 10.3892/ijo.2017.4196
|
5 |
Young Min Kim, Yuna Kim, Jie-Hyun Kim, Jong Suk Park, Su Jung Baik, Jaeyoung Chun, Young Hoon Youn, Hyojin Park. Triglyceride-glucose index is associated with gastroesophageal reflux disease and erosive reflux disease: a health checkup cohort study. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-25536-0
|
6 |
Hao-yu Chen, Qi Li, Ping-ping Zhou, Tian-xiao Yang, Shao-wei Liu, Teng-fei Zhang, Zhen Cui, Jing-jing Lyu, Yan-gang Wang. Mechanisms of Chinese Medicine in Gastroesophageal Reflux Disease Treatment: Data Mining and Systematic Pharmacology Study. Chinese Journal of Integrative Medicine 2023; 29(9): 838 doi: 10.1007/s11655-022-3538-3
|
7 |
Young Min Kim, Jie-Hyun Kim, Su Jung Baik, Da Hyun Jung, Jae Jun Park, Young Hoon Youn, Hyojin Park. Association between skeletal muscle attenuation and gastroesophageal reflux disease: A health check-up cohort study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56702-6
|
8 |
Ellen Richmond, Asad Umar. Mechanisms of esophageal adenocarcinoma formation and approaches to chemopreventive intervention. Seminars in Oncology 2016; 43(1): 78 doi: 10.1053/j.seminoncol.2015.12.001
|
9 |
Sanne J.M. Hoefnagel, Shulin Li, Eva M. Timmer, Sybren L. Meijer, Kausilia K. Krishnadath. Increased PXR and Suppressed T-Cell Signaling Are Associated With Malignant Degeneration of Barrett’s Esophagus. Gastro Hep Advances 2023; 2(1): 63 doi: 10.1016/j.gastha.2022.08.005
|
10 |
Li Tang, Fenglian Xu, Taotao Zhang, Jun Lei, Colin W. Binns, Andy H. Lee. Dietary fibre intake associated with reduced risk of oesophageal cancer in Xinjiang, China. Cancer Epidemiology 2013; 37(6): 893 doi: 10.1016/j.canep.2013.08.012
|
11 |
Chan Hyuk Park, Seung In Seo, Joon Sung Kim, Sun Hyung Kang, Beom Jin Kim, Yoon Jin Choi, Hyo Joo Byun, Jung-Ho Yoon, Sang Kil Lee. Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72082-8
|
12 |
Jianhong Chen, Mourad Wagdy Ali, Li Yan, Shruti G Dighe, James Y Dai, Thomas L Vaughan, Graham Casey, Matthew F Buas. Prioritization and functional analysis of GWAS risk loci for Barrett’s esophagus and esophageal adenocarcinoma. Human Molecular Genetics 2022; 31(3): 410 doi: 10.1093/hmg/ddab259
|
13 |
Hu Li, Nan-Nan Liu, Jian-Rui Li, Mei-Xi Wang, Jia-Li Tan, Biao Dong, Pei Lan, Li-Min Zhao, Zong-Gen Peng, Jian-Dong Jiang. Bicyclol ameliorates advanced liver diseases in murine models via inhibiting the IL-6/STAT3 signaling pathway. Biomedicine & Pharmacotherapy 2022; 150: 113083 doi: 10.1016/j.biopha.2022.113083
|
14 |
Ksenia Maslenkina, Liudmila Mikhaleva, Maxim Naumenko, Rositsa Vandysheva, Michail Gushchin, Dmitri Atiakshin, Igor Buchwalow, Markus Tiemann. Signaling Pathways in the Pathogenesis of Barrett’s Esophagus and Esophageal Adenocarcinoma. International Journal of Molecular Sciences 2023; 24(11): 9304 doi: 10.3390/ijms24119304
|
15 |
Robert E. Schoen, Lisa A. Boardman, Marcia Cruz-Correa, Ajay Bansal, David Kastenberg, Chin Hur, Lynda Dzubinski, Sharon F. Kaufman, Luz M. Rodriguez, Ellen Richmond, Asad Umar, Eva Szabo, Andres Salazar, John McKolanis, Pamela Beatty, Reetesh K. Pai, Aatur D. Singhi, Camille M. Jacqueline, Riyue Bao, Brenda Diergaarde, Ryan P. McMurray, Carrie Strand, Nathan R. Foster, David M. Zahrieh, Paul J. Limburg, Olivera J. Finn. Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma. Clinical Cancer Research 2023; 29(9): 1678 doi: 10.1158/1078-0432.CCR-22-3168
|
16 |
Oliver J. Pickering, Stella P. Breininger, Timothy J. Underwood, Zoë S. Walters. Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma. Cancers 2021; 13(16): 4084 doi: 10.3390/cancers13164084
|
17 |
Yuhan Hao, Ulas Karaoz, Liying Yang, Patrick S. Yachimski, Wenzhi Tseng, Carlos W. Nossa, Weimin Ye, Mengkao Tseng, Michael Poles, Fritz Francois, Morris Traube, Stuart M. Brown, Yu Chen, Manolito Torralba, Richard M. Peek, Eoin L. Brodie, Zhiheng Pei. Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett's esophagus and esophageal adenocarcinoma. International Journal of Cancer 2022; 151(10): 1703 doi: 10.1002/ijc.34191
|
18 |
Jureeporn Chuerduangphui, Tipaya Ekalaksananan, Ponlatham Chaiyarit, Natcha Patarapadungkit, Apinya Chotiyano, Bunkerd Kongyingyoes, Supannee Promthet, Chamsai Pientong, Aamir Ahmad. Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M. PLOS ONE 2018; 13(1): e0192009 doi: 10.1371/journal.pone.0192009
|
19 |
Xinyu Wang, Changhong Yan, Tong Wang, Yajing Li, Zeyi Zheng. Mechanisms of Luteolin Against Gastro-Esophageal Reflux Disease Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation. Cell Biochemistry and Biophysics 2024; doi: 10.1007/s12013-024-01471-x
|
20 |
Qiyi Yi, Yujia Zhao, Ran Xia, Qinqin Wei, Fengmei Chao, Rui Zhang, Po Bian, Lei Lv. TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01491-1
|
21 |
Tuo Li, Dong Wang, Ye Tian, Huijie Yu, Yi Wang, Wei Quan, Weiyun Cui, Lei Zhou, Jieli Chen, Rongcai Jiang, Jianning Zhang. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats. Journal of the Neurological Sciences 2014; 341(1-2): 88 doi: 10.1016/j.jns.2014.04.009
|
22 |
Akueni L. Davelaar, Daniëlle Straub, Navtej S. Buttar, Paul Fockens, Kausilia K. Krishnadath. Active matrix metalloproteases are expressed early on and are high during the Barrett’s esophagus malignancy sequence. Scandinavian Journal of Gastroenterology 2015; 50(3): 321 doi: 10.3109/00365521.2014.940379
|
23 |
E W Lin, T A Karakasheva, P D Hicks, A J Bass, A K Rustgi. The tumor microenvironment in esophageal cancer. Oncogene 2016; 35(41): 5337 doi: 10.1038/onc.2016.34
|
24 |
Xiaoyuan Ma, Lixing Tian, Huaping Liang. Advanced Trauma and Surgery. 2017; : 167 doi: 10.1007/978-981-10-2425-2_12
|